Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/postmj/qgad140 | DOI Listing |
Publication Analysis
Top Keywords
antituberculosis drugs
8
multidrug-resistant tuberculosis
8
prevention treatment
8
mdr-tb
5
clinical progress
4
progress novel
4
novel antituberculosis
4
drugs multidrug-resistant
4
tuberculosis
4
tuberculosis multidrug-resistant
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!